DR. AFSHIN ELI GABAYAN M.D. NPI 1659412757

NPI Information

  • NPI: 1659412757
  • Provider Name: DR. AFSHIN ELI GABAYAN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 8900 WILSHIRE BLVD
    BEVERLY HILLS, CA
    ZIP 90211
  • Phone: (310) 432-8900

Map and Directions

Get Directions

NPI Details

DR. Afshin Eli Gabayan, M.D. is a hematology and oncology internal medicine in Beverly Hills, CA with 32 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Afshin Eli Gabayan, M.D. NPI is 1659412757. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

8900 WILSHIRE BLVD
BEVERLY HILLS, CA
ZIP 90211-958
Phone: (310) 432-8900
Fax: (310) 432-8901

The NPI 1659412757 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Hemoglobin a1c level (HCPCS:83036)
  • Phosphate level (HCPCS:84100)
  • Magnesium level (HCPCS:83735)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Uric acid level, blood (HCPCS:84550)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Testosterone (hormone) level, free (HCPCS:84402)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Urinalysis, manual test (HCPCS:81002)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)

The enumeration date for this NPI number is 2/9/2007 and was last updated on 9/19/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyA055613CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
100A556130MEDICAIDCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.